| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 152, Issue 9 4549-4556, Copyright © 1994 by American Association of Immunologists
ARTICLES |
LW Neese, JE Standing, EJ Olson, M Castro and AH Limper
Thoracic Diseases Research Unit, Mayo Clinic and Foundation, Rochester, MN 55905.
Alveolar macrophages (AMS) initiate inflammation during Pneumocystis carinii pneumonia by releasing cytokines including TNF-alpha. Recent studies suggest that macrophage responses to P. carinii are enhanced by serum opsonization, but the mechanisms of enhancement are not well defined. To determine whether macrophage release of TNF-alpha in response to P. carinii was augmented by immune opsonization, alveolar macrophages obtained from rabbits were cultured with P. carinii that had been opsonized with either nonimmune rabbit serum, immune serum generated against P. carinii, or an affinity-purified polyclonal Ab recognizing the major P. carinii surface Ag gp120. Each experiment also included organisms maintained in media alone (nonopsonized P. carinii). Opsonization of P. carinii with immune serum or gp120 Ab significantly enhanced macrophage TNF-alpha release. Interestingly, however, opsonization with nonimmune serum also increased TNF-alpha response to the organism. Because P. carinii is known to interact with the adhesive glycoproteins, vitronectin (VN) and fibronectin (FN), we hypothesized that they might also augment TNF-alpha release. Opsonization of P. carinii with VN or FN resulted in significant potentiation of macrophage TNF-alpha liberation. We further determined that VN and FN were present in increased quantities in the lower respiratory tract of patients with P. carinii pneumonia compared with normal volunteers. Additionally, VN and FN were demonstrated on the surface of freshly isolated P. carinii organisms by immunoblot analysis. Our study suggests that immune and nonimmune opsonins contribute to host defenses during P. carinii pneumonia by enhancing regional TNF-alpha release in response to the organism.
This article has been cited by other articles:
|
|
 |
|
  J. Wells, C. G. Haidaris, T. W. Wright, and F. Gigliotti Complement and Fc Function Are Required for Optimal Antibody Prophylaxis against Pneumocystis carinii Pneumonia Infect. Immun., January 1, 2006; 74(1): 390 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, S. D. Tachado, N. Patel, J. Zhu, A. Imrich, P. Manfruelli, M. Cushion, T. B. Kinane, and H. Koziel Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro J. Leukoc. Biol., September 1, 2005; 78(3): 665 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Birdsall, W. J. Porter, D. M. Green, J. Rubio, J. Trial, and R. D. Rossen Impact of Fibronectin Fragments on the Transendothelial Migration of HIV-Infected Leukocytes and the Development of Subendothelial Foci of Infectious Leukocytes J. Immunol., August 15, 2004; 173(4): 2746 - 2754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Lasbury, P. Lin, D. Tschang, P. J. Durant, and C.-H. Lee Effect of Bronchoalveolar Lavage Fluid from Pneumocystis carinii- Infected Hosts on Phagocytic Activity of Alveolar Macrophages Infect. Immun., April 1, 2004; 72(4): 2140 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Swain, S. J. Lee, M. C. Nussenzweig, and A. G. Harmsen Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility to Pneumocystis carinii Infection In Vivo Infect. Immun., November 1, 2003; 71(11): 6213 - 6221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Lasbury, X. Tang, P. J. Durant, and C.-H. Lee Effect of Transcription Factor GATA-2 on Phagocytic Activity of Alveolar Macrophages from Pneumocystis carinii-Infected Hosts Infect. Immun., September 1, 2003; 71(9): 4943 - 4952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Utz, A. H. Limper, S. Kalra, U. Specks, J. P. Scott, Z. Vuk-Pavlovic, and D. R. Schroeder Etanercept for the Treatment of Stage II and III Progressive Pulmonary Sarcoidosis Chest, July 1, 2003; 124(1): 177 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lebron, R. Vassallo, V. Puri, and A. H. Limper Pneumocystis carinii Cell Wall {beta}-Glucans Initiate Macrophage Inflammatory Responses through NF-{kappa}B Activation J. Biol. Chem., June 27, 2003; 278(27): 25001 - 25008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Yong, Z. Vuk-Pavlovic, J. E. Standing, E. C. Crouch, and A. H. Limper Surfactant Protein D-Mediated Aggregation of Pneumocystis carinii Impairs Phagocytosis by Alveolar Macrophages Infect. Immun., April 1, 2003; 71(4): 1662 - 1671. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Lasbury, P. J. Durant, M. S. Bartlett, J. W. Smith, and C.-H. Lee Correlation of Organism Burden and Alveolar Macrophage Counts during Infection with Pneumocystis carinii and Recovery Clin. Vaccine Immunol., March 1, 2003; 10(2): 293 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vassallo, T. J. Kottom, J. E. Standing, and A. H. Limper Vitronectin and Fibronectin Function as Glucan Binding Proteins Augmenting Macrophage Responses to Pneumocystis carinii Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 203 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Vuk-Pavlovic, J. E. Standing, E. C. Crouch, and A. H. Limper Carbohydrate Recognition Domain of Surfactant Protein D Mediates Interactions with Pneumocystis carinii Glycoprotein A Am. J. Respir. Cell Mol. Biol., April 1, 2001; 24(4): 475 - 484. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. E. WISNIOWSKI, R. W. SPECH, M. WU, N. A. DOYLE, R. PASULA, and W. J. MARTIN II Vitronectin Protects Alveolar Macrophages from Silica Toxicity Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 733 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Vassallo, J. E. Standing, and A. H. Limper Isolated Pneumocystis carinii Cell Wall Glucan Provokes Lower Respiratory Tract Inflammatory Responses J. Immunol., April 1, 2000; 164(7): 3755 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Walzer Immunological Features of Pneumocystis carinii Infection in Humans Clin. Vaccine Immunol., March 1, 1999; 6(2): 149 - 155. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Simpson-Haidaris, M.-A. Courtney, T. W. Wright, R. Goss, A. Harmsen, and F. Gigliotti Induction of Fibrinogen Expression in the Lung Epithelium during Pneumocystis carinii Pneumonia Infect. Immun., September 1, 1998; 66(9): 4431 - 4439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Koziel, D. S. Phelps, J. A. Fishman, M. Y. K. Armstrong, F. F. Richards, and R. M. Rose Surfactant Protein-A Reduces Binding and Phagocytosis of Pneumocystis carinii by Human Alveolar Macrophages In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 1998; 18(6): 834 - 843. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. L. Yu and A. H. Limper Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-alpha -mediated mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1103 - L1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Wright, C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein Analysis of Cytokine mRNA Profiles in the Lungs of Pneumocystis carinii-infected Mice Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 491 - 500. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
